pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Stroke in 1 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lämmer, AB | 1 |
| Beck, A | 1 |
| Grummich, B | 1 |
| Förschler, A | 1 |
| Krügel, T | 1 |
| Kahn, T | 1 |
| Schneider, D | 1 |
| Illes, P | 1 |
| Franke, H | 1 |
| Krügel, U | 1 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Stroke
| Article | Year |
|---|---|
The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo.
Topics: Animals; Cell Death; Electroencephalography; Immunohistochemistry; In Situ Nick-End Labeling; Infarc | 2011 |